FDA loosens side ef­fect re­port­ing re­quire­ments for some CAR-T ther­a­pies

The FDA is no longer re­quir­ing the re­port­ing of two com­mon — and some­times se­ri­ous — side ef­fects for a hand­ful of CAR-T ther­a­pies in an ef­fort …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.